Basic Information
Curida provides contract development and manufacturing solutions globally for European pharmaceutical and biotechnology companies. Curida specializes in sterile and non-sterile liquid production, with expertise in Blow-Fill-Seal (“BFS”) and nasal spray technologies, serving the small molecule pharmaceuticals and medical devices markets. In biologics, Curida offers upstream and downstream processing services for monoclonal antibodies used in in vitro diagnostics.
Curida Holding AS
The Kingdom of Norway
51~100 people
January 01, 1974
--

